Projected Income Statement: Merck KGaA

Forecast Balance Sheet: Merck KGaA

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 12,357 10,662 8,902 8,328 7,959 6,702 4,896 2,628
Change - -13.72% -16.51% -6.45% -4.43% -15.79% -26.95% -46.32%
Announcement Date 05/03/20 04/03/21 03/03/22 02/03/23 07/03/24 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Merck KGaA

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
CAPEX 1 812.9 1,412 1,066 1,531 2,024 1,952 1,971 1,972
Change - 73.76% -24.57% 43.73% 32.14% -3.55% 0.97% 0.05%
Free Cash Flow (FCF) 1 2,043 2,065 3,550 2,728 1,915 2,761 3,053 3,473
Change - 1.05% 71.95% -23.17% -29.8% 44.17% 10.61% 13.73%
Announcement Date 05/03/20 04/03/21 03/03/22 02/03/23 07/03/24 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Merck KGaA

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

        
EBITDA Margin (%) 27.15% 29.66% 31% 30.81% 28% 28.06% 29.66% 30.41%
EBIT Margin (%) 13.13% 17.02% 21.23% 20.12% 17.19% 18.11% 20.24% 21.34%
EBT Margin (%) 10.74% 15% 19.93% 19.28% 16.6% 17.59% 19.76% 20.93%
Net margin (%) 8.17% 11.33% 15.52% 14.96% 13.45% 13.87% 15.62% 16.55%
FCF / Net Income (%) 12.65% 11.78% 18.03% 12.27% 9.12% 12.98% 13.59% 14.69%

Profitability

        
ROA 3.27% 4.64% 8.7% 9.31% 7.61% 6.53% 7.47% 7.82%
ROE 13.79% 16.69% 19.81% 18.5% 14.03% 13.49% 14.55% 14.61%

Financial Health

        
Leverage (Debt/EBITDA) 2.82x 2.05x 1.46x 1.22x 1.35x 1.12x 0.73x 0.37x
Debt / Free cash flow 6.05x 5.16x 2.51x 3.05x 4.16x 2.43x 1.6x 0.76x

Capital Intensity

        
CAPEX / Current Assets (%) 5.03% 8.06% 5.41% 6.89% 9.64% 9.18% 8.77% 8.34%
CAPEX / EBITDA (%) 18.54% 27.16% 17.46% 22.36% 34.42% 32.72% 29.57% 27.43%
CAPEX / FCF (%) 39.78% 68.41% 30.01% 56.14% 105.68% 70.7% 64.54% 56.78%

Items per share

        
Cash flow per share 1 6.576 7.997 10.62 9.796 8.703 10.49 11.59 12.87
Change - 21.6% 32.75% -7.73% -11.15% 20.56% 110.48% 111.01%
Dividend per Share 1 1.3 1.4 1.85 2.2 2.2 2.324 2.549 2.735
Change - 7.69% 32.14% 18.92% 0% 5.62% 109.71% 107.3%
Book Value Per Share 1 41.09 39.14 49.08 59.63 61.36 66.17 72.06 78.66
Change - -4.75% 25.41% 21.5% 2.9% 7.84% 108.9% 109.15%
EPS 1 3.04 4.57 7.03 7.65 6.49 6.843 8.247 9.252
Change - 50.33% 53.83% 8.82% -15.16% 5.44% 120.52% 112.19%
Nbr of stocks (in thousands) 434,778 434,778 434,778 434,778 434,778 434,778 434,778 434,778
Announcement Date 05/03/20 04/03/21 03/03/22 02/03/23 07/03/24 - - -
1EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
155.00EUR
Average target price
180.81EUR
Spread / Average Target
+16.65%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Financials Merck KGaA